Walgreens’ stock had a disappointing performance during the course of the year but there as been some recovery after a decent result. The company delivered an all-around beat in the last quarter. As a result of construction and supply-side delays, the pace of Walgreen is slower. In the quarter pharmacy performance benefitted from the improved trends from maintenance medications and seasonal scripts. Walgreens is making consistent progress and important strides to build the U.S. Healthcare segmen ....

22 Oct 2022
Walgreens Boots Alliance: The CareCentrix Acquisition & Other Drivers, Financial Forecasts, DCF & Comparables Valuation, ESG & Other Risks (10/22)

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Walgreens Boots Alliance: The CareCentrix Acquisition & Other Drivers, Financial Forecasts, DCF & Comparables Valuation, ESG & Other Risks (10/22)
- Published:
22 Oct 2022 -
Author:
Ishan Majumdar -
Pages:
27 -
Walgreens’ stock had a disappointing performance during the course of the year but there as been some recovery after a decent result. The company delivered an all-around beat in the last quarter. As a result of construction and supply-side delays, the pace of Walgreen is slower. In the quarter pharmacy performance benefitted from the improved trends from maintenance medications and seasonal scripts. Walgreens is making consistent progress and important strides to build the U.S. Healthcare segmen ....